Brief: Antisense Therapeutics Says European Medicines Agency Adopts Positive Final Opinion For Drug

Percheron Therapeutics

01/11/2021 01:43

Nov 1 (Reuters) - Antisense Therapeutics Ltd  ANP.AX :
    * PAEDIATRIC COMMITTEE OF EUROPEAN MEDICINES AGENCY ADOPTED
A
POSITIVE FINAL OPINION FOR DEVELOPMENT OF ATL1102
    * RECEIVED FIRM COMMITMENTS TO RAISE A$20.0 MILLION AT
A$0.24 PER
SHARE
    * ALSO INTENDS TO CONDUCT A NON-UNDERWRITTEN 1 FOR 9.4
ENTITLEMENT
OFFER TO RAISE A$16.8 MILLION AT SAME PRICE AS PLACEMENT

Source text for Eikon:  ID:nASX8XhcKc 
Further company coverage:  ANP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))